Keywords: kos, takeda, sign, co-promotion, deal, pharmaceuticals, entered
Kos and Takeda sign US co-promotion deal
Article | 10 November 2003
Kos Pharmaceuticals and Takeda have entered into a three-year agreementto co-promote Kos' Niaspan (extended-release niacin) and Advicor (extended-release niacin/lovastatin) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
